Clinical scenario
Rose, 88, has recently moved into residential aged care as her needs have increased. She takes 10 regular medicines. During a medication review, the pharmacist identifies three medicines that could potentially be deprescribed: one is causing adverse effects, one has an uncertain ongoing benefit, and another is no longer needed because the symptoms it was treating have resolved.
What does the guideline suggest?
When several medicines are candidates for deprescribing, the deprescribing guideline (available at deprescribing.com ) suggests deciding the sequence of deprescribing in partnership with the person, considering:
risk of harm from continuing, including adverse effects, interactions and treatment burden
benefit from continuing, including whether there is a clear ongoing indication and meaningful expected benefit
risk of withdrawal or symptom recurrence
cost and treatment burden.
A prioritisation matrix to guide this process is available on deprescribing.com .
Tapering medicines safely



